Abstract
Background: Several functional and nonfunctional CYP2D6 variants have been associated with interindividual and interethnic variability in pharmacological responses. The aim of this article was to study the diversity and the interpopulation relationships of CYP2D6 variants of south Native Mexicans to define predicted phenotypes.
Contents: A fully systematic review of CYP2D6 variants reported in Amerindian populations before 2015 was performed (NCBI, Google Scholar, and 1000 Genomes Project databases). Allele data were analyzed by methods such as heat map, dissimilarity matrix, dendogram, and principal component analysis using complete-linkage clustering method. Five original studies on CYP2D6 covering 13 Native Mexican populations were identified; three of these described CYP2D6 allele frequencies were in south Native Mexican populations. Overall, CYP2D6 allele variability is scarce in southern Native Mexican populations: besides the functional alleles *1 and *2 and the null variant *4, the other variants have frequencies <0.05. This implies that most of the southern Native Mexican populations may be considered CYP2D6 extended metabolizers. The statistical analyses tend to cluster the native communities by their geographical origin, but in a disperse pattern suggesting distinct subpopulation structures.
Conclusions: CYP2D6 functional variants are prevalent in Native Mexicans, and they may be predicted as extended drug metabolizers. In addition, allele frequencies are related to the geographic distribution of the Amerindian groups and display important population stratification.
Acknowledgments
We acknowledge the financial support of AEXCID-Gobierno de Extremadura, Spain (AEXCID 13IA001 to SIFF) and the Red Iberoamericana de Farmacogenümica (RIBEF) CEIBA Consortium (www.ribef.com).
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Conflict of interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. DiCarlo FJ, Rendic S. Human cytochrome P450 enzymes: a status report summarazing their reactions, inducers and inhibitors. Drug Metab Rev 1997;29:413–580.10.3109/03602539709037591Search in Google Scholar PubMed
2. CYP2D6 allele nomenclature. Available at: http://www.cypalleles.ki.se/cyp2d6.htm. Accessed on 15 May, 2015.Search in Google Scholar
3. Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994;270:414–23.10.1016/S0022-3565(25)22379-5Search in Google Scholar
4. Chakraborty R. Sample size requirements for addressing the population genetic issues of forensic use of DNA typing. Hum Biol 1992;64:141–59.Search in Google Scholar
5. Zhou S-F, Liu J-P, Chowbay B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev 2009;41:89–295.10.1080/03602530902843483Search in Google Scholar PubMed
6. INEGI census 2010 [Internet]. [cited 2015 Feb 2]. Available at: http://www3.inegi.org.mx/sistemas/iter/default.asp.Search in Google Scholar
7. Comisión Nacional para el Desarrollo de los Pueblos Indígenas. Comisión Nacional para el Desarrollo de los Pueblos Indígenas [Internet]. 2014. Available at: http://www.cdi.gob.mx. Accessed on 18 May, 2015.Search in Google Scholar
8. Instituto Nacional de Lenguas Indigenas. CATALOGO de las Lenguas Indígenas Nacionales: Variantes Lingüísticas de México con sus autodenominaciones y referencias geoestadísticas. D Of la Fed [Internet]. 2008; Available at: http://www.inali.gob.mx/pdf/CLIN_completo.pdf. Accessed on 18 May, 2015.Search in Google Scholar
9. Silva-Zolezzi I, Hidalgo-Miranda A, Estrada-Gil J, Fernandez-Lopez JC, Uribe-Figueroa L, Contreras A, et al. Analysis of genomic diversity in Mexican mestizo populations to develop genomic medicine in Mexico. Proc Natl Acad Sci USA 2009;106:8611–6.10.1073/pnas.0903045106Search in Google Scholar PubMed PubMed Central
10. Martinez-Fierro ML, Beuten J, Leach RJ, Parra EJ, Cruz-Lopez M, Rangel-Villalobos H, et al. Ancestry informative markers and admixture proportions in northeastern Mexico. J Hum Genet 2009;54:504–9.10.1038/jhg.2009.65Search in Google Scholar PubMed
11. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904–9.10.1038/ng1847Search in Google Scholar PubMed
12. Patterson N, Price AL, Reich D. Population structure and eigenanalysis. PLoS Genet 2006;2:e190.10.1371/journal.pgen.0020190Search in Google Scholar PubMed PubMed Central
13. Revell LJ. Phytools, version 0.4-56: an R package for phylogenetic comparative biology (and other things). Methods Ecol Evol 2012;3:217–23.10.1111/j.2041-210X.2011.00169.xSearch in Google Scholar
14. Lazalde-Ramos BP, Martínez-Fierro Mde L, Galaviz-Hernández C, Garza-Veloz I, Naranjo ME, Sosa-Macías M, et al. CYP2D6 gene polymorphisms and predicted phenotypes in eight indigenous groups from northwestern Mexico. Pharmacogenomics 2013;15:339–48.10.2217/pgs.13.203Search in Google Scholar PubMed
15. Salazar-Flores J, Torres-Reyes LA, Martínez-Cortés G, Rubi-Castellanos R, Sosa-Macías M, Muñoz-Valle JF, et al. Distribution of CYP2D6 and CYP2C19 polymorphisms associated with poor metabolizer phenotype in five Amerindian groups and western mestizos from Mexico. Genet Test Mol Biomarkers. 2012;16:1098–104.10.1089/gtmb.2012.0055Search in Google Scholar PubMed PubMed Central
16. Sosa-Macías M, Dorado P, Alanis-Bañuelos RE, Llerena A, Lares-Asseff I. Influence of CYP2D6 deletion, multiplication, -1584C→G, 31G→A and 2988G→a gene polymorphisms on dextromethorphan metabolism among Mexican tepehuanos and mestizos. Pharmacology 2010;86:30–6.10.1159/000314334Search in Google Scholar PubMed
17. López-López M, Peñas-Lledó E, Dorado P, Ortega A, Corona T, Ochoa A, et al. CYP2D6 genetic polymorphisms in Southern Mexican Mayan Lacandones and mestizos from Chiapas. Pharmacogenomics 2014;15:1859–65.10.2217/pgs.14.139Search in Google Scholar PubMed
18. Pérez-Páramo YX, Hernández-Cabrera F, Dorado P, Llerena-Ruiz A, Muñoz-Jiménez S, Ortiz-López R, et al. Inter-ethnic relationships of CYP2D6 variants in native and mestizo populations sharing the same ecosystem. Pharmacogenomics 2015;16:703–12.10.2217/pgs.15.24Search in Google Scholar PubMed
19. López M, Guerrero J, Jung-Cook H, Alonso ME. CYP2D6 genotype and phenotype determination in a Mexican mestizo population. Eur J Clin Pharmacol [Internet]. 2005;61:749–54.10.1007/s00228-005-0038-2Search in Google Scholar PubMed
20. Contreras AV, Monge-Cazares T, Alfaro-Ruiz L, Hernandez-Morales S, Miranda-Ortiz H, Carrillo-Sanchez K, et al. Resequencing, haplotype construction and identification of novel variants of CYP2D6 in Mexican mestizos. Pharmacogenomics 2011;12:745–56.10.2217/pgs.11.8Search in Google Scholar PubMed
21. The 1000 Genomes Project Consortium*. An integrated map of genetic variation from 1092 human genomes. Nature 2012;491:56–65.10.1038/nature11632Search in Google Scholar PubMed PubMed Central
22. Wang S, Lewis CM, Jakobsson M, Ramachandran S, Ray N, Bedoya G, et al. Genetic variation and population structure in native Americans. PLoS Genet 2007;3:e185.10.1371/journal.pgen.0030185Search in Google Scholar PubMed PubMed Central
23. Johnson NA, Coram MA, Shriver MD, Romieu I, Barsh GS, London SJ, et al. Ancestral components of admixed genomes in a Mexican cohort. PLoS Genet 2011;7:e1002410.10.1371/journal.pgen.1002410Search in Google Scholar PubMed PubMed Central
24. Sachse C, Brockmöller J, Bauer S, Roots I. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am J Hum Genet 1997;60:284–95.Search in Google Scholar
25. Moreno-Estrada A, Gignoux CR, Fernández-López JC, Zakharia F, Sikora M, Contreras AV, et al. Human genetics. The genetics of Mexico recapitulates Native American substructure and affects biomedical traits. Science 2014;344:1280–5.10.1126/science.1251688Search in Google Scholar PubMed PubMed Central
26. Llerena A, Dorado P, Peñas-Lledó EM, Cáceres MC, De la Rubia A. Low frequency of CYP2D6 poor metabolizers among schizophrenia patients. Pharmacogenomics J 2007;7:408–10.10.1038/sj.tpj.6500439Search in Google Scholar PubMed
27. Fuselli S, de Filippo C, Mona S, Sistonen J, Fariselli P, Destro-Bisol G, et al. Evolution of detoxifying systems: the role of environment and population history in shaping genetic diversity at human CYP2D6 locus. Pharmacogenet Genomics 2010;20:485–99.10.1097/FPC.0b013e32833bba25Search in Google Scholar PubMed
©2015 by De Gruyter
Articles in the same Issue
- Frontmatter
- Review
- Clinical pharmacy service practice in a Chinese tertiary hospital
- Reviews in Population Pharmacogenomics
- CYP2D6 in Amerindians from Southern Mexico: low variability and higher frequency of functional alleles
- Pharmacogenetics of healthy volunteers in Puerto Rico
- Original Articles
- ABCG2/BCRP interaction with the sea grass Thalassia testudinum
- Effect of rifampicin pretreatment on the oral bioavailability of domperidone in healthy human volunteers
- Efficacy of subgingivally delivered atorvastatin and simvastatin as an adjunct to scaling and root planing
- Case Report
- Fluvoxamine-associated oscillopsia and a role for personalized medication dosing
- Acknowledgment
Articles in the same Issue
- Frontmatter
- Review
- Clinical pharmacy service practice in a Chinese tertiary hospital
- Reviews in Population Pharmacogenomics
- CYP2D6 in Amerindians from Southern Mexico: low variability and higher frequency of functional alleles
- Pharmacogenetics of healthy volunteers in Puerto Rico
- Original Articles
- ABCG2/BCRP interaction with the sea grass Thalassia testudinum
- Effect of rifampicin pretreatment on the oral bioavailability of domperidone in healthy human volunteers
- Efficacy of subgingivally delivered atorvastatin and simvastatin as an adjunct to scaling and root planing
- Case Report
- Fluvoxamine-associated oscillopsia and a role for personalized medication dosing
- Acknowledgment